Drugs / Autologous Dendritic Cells (DC)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT00313508 Background | Feb 2006 → Mar 2012 | cutaneous melanoma, ocular melanoma | H. Lee Moffitt Cancer Center and Research Institute | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous Dendritic Cells (DC) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00313508 ↗ |
| Modality | Cell therapy | “autologous dendritic cells (DC)” NCT00313508 ↗ |
| Route | Other | “Given intranodally” NCT00313508 ↗ |